GlassScriptPhysician profile
Glori Short
NPI 1588687776
$6,229.63
in general payments reported to CMS, 2019-2025
34 companies · $697 in 2025
The $697 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,906 · 2020: $402 · 2021: $385 · 2022: $499 · 2023: $763 · 2024: $577 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.56 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,654.82 | 2019-2020 | |
| Medtronic, INC. | $638.46 | 2021-2025 | Interstim |
| Pfizer INC. | $455.22 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $448.45 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $406.48 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $203.53 | 2021-2025 | |
| Duchesnay USA Incorporated | $137.28 | 2019 | |
| Channel Medsystems, INC. | $127.64 | 2023-2024 | |
| Axonics, INC. | $126.00 | 2023-2024 | Axonics |
| Amgen INC. | $124.61 | 2019-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $94.82 | 2019-2025 | |
| Millicent US INC | $69.40 | 2024 | Intrarosa |
| Hologic Sales and Service, LLC | $68.69 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Abbvie INC. | $65.30 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Takeda Pharmaceuticals U.S.A., INC. | $57.48 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $50.79 | 2022 | |
| Currax Pharmaceuticals LLC | $43.66 | 2021-2022 | |
| Exeltis, USA INC. | $42.58 | 2023-2025 | Slynd |
| Myovant Sciences INC. | $41.06 | 2021-2022 | |
| Exact Sciences Corporation | $39.68 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $36.20 | 2024-2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $35.39 | 2022 | |
| Amag Pharmaceuticals, INC. | $35.31 | 2019 | |
| Boston Scientific Corporation | $32.63 | 2019-2025 | Axonics |
| Organon LLC | $31.95 | 2024 | |
| Minerva Surgical, INC | $31.92 | 2019-2024 | |
| Intuitive Surgical, INC. | $21.43 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.24 | 2025 | Qelbree |
| Shield Therapeutics INC | $19.37 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.98 | 2019 | |
| Avanos Medical | $17.70 | 2024 | On-Q* Pump and Accessories |
| Eisai INC. | $11.37 | 2019 | |
| Therapeuticsmd, INC. | $11.11 | 2020 | |
| Novo Nordisk INC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glori Short listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.